Diclofenac Impurity 21 | CAS 626239-02-9 - Request Quote
Diclofenac Impurity 21
| SZ CAT No: | SZ-D028043 |
| CAS No | 626239-02-9 |
| Mol.F. | C14H10Cl3NO |
| Mol.Wt. | 314.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Diclofenac Impurity 21 is chemically 2-Chloro-N-(2,4-dichlorophenyl)-N-phenylacetamide. Diclofenac Impurity 21 is supplied with detailed characterization data compliant with regulatory guideline. Diclofenac Impurity 21 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Diclofenac.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 626239-02-9
Purchase 626239-02-9
Order 626239-02-9
Enquire 626239-02-9
price of 626239-02-9
626239-02-9 Supplier
626239-02-9 Manufacturer
626239-02-9 Exporter
buy high quality Diclofenac Impurity 21
Purchase Diclofenac Impurity 21
Diclofenac Impurity 21 suppliers
Diclofenac Impurity 21 manufacturers
Diclofenac Impurity 21 price
Order Diclofenac Impurity 21
Enquire Diclofenac Impurity 21
Diclofenac Impurity 21 cost
Diclofenac Impurity 21 Supplier
Diclofenac Impurity 21 Distributor
Diclofenac Impurity 21 for Method Validation
Diclofenac Reference Standard
Diclofenac Impurity 21 for ANDA Filing
Diclofenac Impurity 21 for Forced Degradation Studies
Diclofenac Impurity 21 Identification Standards
Diclofenac Impurity 21 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.